Loading…

Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice

We studied ionotropic glutamate receptor subtypes and the effect of chronic treatment with NBQX [6‐nitro‐7‐sulphamoyl‐benzo(F)quinoxaline‐2,3‐dione], a selective (rs)‐α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor antagonist, in the spinal cord of mnd mice. NBQX (8 mg/kg daily...

Full description

Saved in:
Bibliographic Details
Published in:The European journal of neuroscience 1999-05, Vol.11 (5), p.1705-1710
Main Authors: Mennini, T., Cagnotto, A., Carvelli, L., Comoletti, D., Manzoni, C., Muzio, V., Rizzi, M., Vezzani, A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We studied ionotropic glutamate receptor subtypes and the effect of chronic treatment with NBQX [6‐nitro‐7‐sulphamoyl‐benzo(F)quinoxaline‐2,3‐dione], a selective (rs)‐α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor antagonist, in the spinal cord of mnd mice. NBQX (8 mg/kg daily i.p. for 3 weeks starting from 24 weeks old) significantly improved the behavioural scores (hind leg extension reflex, cage rung grasping and gait) in mnd mice, measured after the last drug injection, and increased the number of mice with ‘normal’ gait (from 50% to 90%, P
ISSN:0953-816X
1460-9568
DOI:10.1046/j.1460-9568.1999.00588.x